期刊文献+

血清hs-CRP测定在妊娠糖尿病患者中的临床意义 被引量:4

Clinical Significance of Detection of Serum High-sensitivity C-reactive Protein in Patients with Gestational Diabetes Mellitus
原文传递
导出
摘要 目的探讨血清超敏C反应蛋白(hs-CRP)在妊娠糖尿病(GDM)患者发病中的作用。方法利用ELISA方法检测51例妊娠糖尿病患者和45例糖耐量正常(NGT)孕妇的血清hs-CRP水平,采用葡萄糖氧化酶法及放射免疫法测定空腹葡萄糖(FPG)、空腹胰岛素(FIns)水平,计算胰岛素抵抗指数(HOMA-IR)。结果(1)GDM组FPG[(6.09±0.79)mmol/L]、FIns[(17.03±7.58)mIU/L]、HOMA-IR(3.88±2.01)、hs-CRP[(11.07±3.69)mg/L]分别高于NGT组[(4.30±0.50)mmol/L、(13.39±3.17)mIU/L、(2.56±0.69)和(6.08±2.54)mg/L](P<0.01);(2)血清hs-CRP水平与HOMA-IR(r=0.288,P<0.01)、FIns(r=0.301,P<0.01)、BMI(r=0.196,P<0.01)相关。结论慢性炎症与胰岛素抵抗密切相关,hs-CRP升高是GDM的发病的一个预测因子。 Objective To explore the clinical significance of detecting serum high- sensitivity C- reactive protein (hs - CRP) levels in patients with gestational diabetes mellitus (GDM). Methods Fifty - one patients with GDM and 45 pregnant women with normal glucose tolerance (NGT) were observed. ELISA was used to evaluate serum hs- CRP level. Fasting plasma glucose (FPG) and fasting insulin (Fins) were measured by oxidized assay and immunoradioassay. Insulin resistance index (HOMA- IR) was calculated. Results The levels of FPG, Fins, HOMA- IR and hs - CRP in GDM group [ (6.09 ± 0.79)mmol/L, ( 17.03 ± 7.58)mlU/L, (3.88 ± 2.01 ), and ( 11.07 ± 3.69) mg/L] were significantly higher than those of normal group E(4.30 ± 0.50)mmol/L, (13.39 ± 3.17)mlU/L, (2.59 ± 0.69), and (6.08 ± 2..54)mg/L] (P〈0.01). Circulation level of hs-CRP was correlated with HOMA- IR (r=0.288, P〈0.01), Fins(r=0.301, P〈0.01), and BMI(r=0. 196, P 〈 0.01). Conclusions The data support the hypothesis that low grade systemic inflammation is closely related to insulin resistance, hs- CRP is a strong predictor for the development of GDM.
出处 《实用预防医学》 CAS 2009年第2期339-340,共2页 Practical Preventive Medicine
基金 深圳市科技和信息局资助课题(200602037)
关键词 妊娠糖尿病 超敏C反应蛋白 胰岛素抵抗 Gestational diabetes mellitus High sensitive C- reactive protein Insulin resistance
  • 相关文献

参考文献8

  • 1Nakanishi S, Yamane K, Kamei N, et al. Elevated C- reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans[ J ]. Diabetes Care, 2003,26 : 2754 - 2757.
  • 2无.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华围产医学杂志,2007,10(4):283-285. 被引量:150
  • 3Agardh CD, Aberg A, Norden NE. Glucose levels and insulin secretion during a 75g glucose challenge test in normal pregnancy[J]. J Intern Med, 1996,240:303 - 309.
  • 4Smirnakis KV, Martinez A, Blatman KH, et al. Early pregnancy insulin resistance and subsequent gestational diabetes mellitus[J]. Diabetes Care,2005,28 : 1207 - 1208.
  • 5Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance[J]. Diabetes Care, 1998,21:403 - 408.
  • 6Qiu C, Sorensen TK, Luthy DA, et al. A prospective study of maternal serum C- reactive protein (CRP) concentrationsand risk of gestational diabetes mellitus[ J ]. Paediatr Perinat Epidemiol, 2004,18 ( 5 ) ; 377 - 384.
  • 7Pickup JC, Cook MA. Is type Ⅱ diabetes mellitus a disease of innate immune system [J ]. Diabetologia, 1998,41 (10) : 1241 - 1248.
  • 8Barden A ,Singh R, Wahers BN, ct al. Factors predisposing to preeclampsia in women with gestational diabetes [ J ]. J Hypertens, 2004, 22(12):2371-2378.

共引文献149

同被引文献41

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部